Cargando…

Neurofeedback in patients with frontal brain lesions: A randomized, controlled double-blind trial

BACKGROUND: Frontal brain dysfunction is a major challenge in neurorehabilitation. Neurofeedback (NF), as an EEG-based brain training method, is currently applied in a wide spectrum of mental health conditions, including traumatic brain injury. OBJECTIVE: This study aimed to explore the capacity of...

Descripción completa

Detalles Bibliográficos
Autores principales: Annaheim, Christine, Hug, Kerstin, Stumm, Caroline, Messerli, Maya, Simon, Yves, Hund-Georgiadis, Margret
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521487/
https://www.ncbi.nlm.nih.gov/pubmed/36188178
http://dx.doi.org/10.3389/fnhum.2022.979723
_version_ 1784799849681518592
author Annaheim, Christine
Hug, Kerstin
Stumm, Caroline
Messerli, Maya
Simon, Yves
Hund-Georgiadis, Margret
author_facet Annaheim, Christine
Hug, Kerstin
Stumm, Caroline
Messerli, Maya
Simon, Yves
Hund-Georgiadis, Margret
author_sort Annaheim, Christine
collection PubMed
description BACKGROUND: Frontal brain dysfunction is a major challenge in neurorehabilitation. Neurofeedback (NF), as an EEG-based brain training method, is currently applied in a wide spectrum of mental health conditions, including traumatic brain injury. OBJECTIVE: This study aimed to explore the capacity of Infra-Low Frequency Neurofeedback (ILF-NF) to promote the recovery of brain function in patients with frontal brain injury. MATERIALS AND METHODS: Twenty patients hospitalized at a neurorehabilitation clinic in Switzerland with recently acquired, frontal and optionally other brain lesions were randomized to either receive NF or sham-NF. Cognitive improvement was assessed using the Frontal Assessment Battery (FAB) and the Test of Attentional Performance (TAP) tasks regarding intrinsic alertness, phasic alertness and impulse control. RESULTS: With respect to cognitive improvements, there was no significant difference between the two groups after 20 sessions of either NF or sham-NF. However, in a subgroup of patients with predominantly frontal brain lesions, the improvements measured by the FAB and intrinsic alertness were significantly higher in the NF-group. CONCLUSION: This is the first double-blind controlled study using NF in recovery from brain injury, and thus also the first such study of ILF NF. Although the result of the subgroup has limited significance because of the small number of participants, it accentuates the trend seen in the whole group regarding the FAB and intrinsic alertness (p = 0.068, p = 0.079, respectively). We therefore conclude that NF could be a promising candidate promoting the recoveryfrom frontal brain lesions. Further studies with larger numbers of patients and less lesion heterogeneity are needed to verify the usefulness of NF in the neurorehabilitation of patients with frontal brain injury (NCT02957695 ClinicalTrials.gov).
format Online
Article
Text
id pubmed-9521487
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95214872022-09-30 Neurofeedback in patients with frontal brain lesions: A randomized, controlled double-blind trial Annaheim, Christine Hug, Kerstin Stumm, Caroline Messerli, Maya Simon, Yves Hund-Georgiadis, Margret Front Hum Neurosci Human Neuroscience BACKGROUND: Frontal brain dysfunction is a major challenge in neurorehabilitation. Neurofeedback (NF), as an EEG-based brain training method, is currently applied in a wide spectrum of mental health conditions, including traumatic brain injury. OBJECTIVE: This study aimed to explore the capacity of Infra-Low Frequency Neurofeedback (ILF-NF) to promote the recovery of brain function in patients with frontal brain injury. MATERIALS AND METHODS: Twenty patients hospitalized at a neurorehabilitation clinic in Switzerland with recently acquired, frontal and optionally other brain lesions were randomized to either receive NF or sham-NF. Cognitive improvement was assessed using the Frontal Assessment Battery (FAB) and the Test of Attentional Performance (TAP) tasks regarding intrinsic alertness, phasic alertness and impulse control. RESULTS: With respect to cognitive improvements, there was no significant difference between the two groups after 20 sessions of either NF or sham-NF. However, in a subgroup of patients with predominantly frontal brain lesions, the improvements measured by the FAB and intrinsic alertness were significantly higher in the NF-group. CONCLUSION: This is the first double-blind controlled study using NF in recovery from brain injury, and thus also the first such study of ILF NF. Although the result of the subgroup has limited significance because of the small number of participants, it accentuates the trend seen in the whole group regarding the FAB and intrinsic alertness (p = 0.068, p = 0.079, respectively). We therefore conclude that NF could be a promising candidate promoting the recoveryfrom frontal brain lesions. Further studies with larger numbers of patients and less lesion heterogeneity are needed to verify the usefulness of NF in the neurorehabilitation of patients with frontal brain injury (NCT02957695 ClinicalTrials.gov). Frontiers Media S.A. 2022-09-15 /pmc/articles/PMC9521487/ /pubmed/36188178 http://dx.doi.org/10.3389/fnhum.2022.979723 Text en Copyright © 2022 Annaheim, Hug, Stumm, Messerli, Simon and Hund-Georgiadis. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Human Neuroscience
Annaheim, Christine
Hug, Kerstin
Stumm, Caroline
Messerli, Maya
Simon, Yves
Hund-Georgiadis, Margret
Neurofeedback in patients with frontal brain lesions: A randomized, controlled double-blind trial
title Neurofeedback in patients with frontal brain lesions: A randomized, controlled double-blind trial
title_full Neurofeedback in patients with frontal brain lesions: A randomized, controlled double-blind trial
title_fullStr Neurofeedback in patients with frontal brain lesions: A randomized, controlled double-blind trial
title_full_unstemmed Neurofeedback in patients with frontal brain lesions: A randomized, controlled double-blind trial
title_short Neurofeedback in patients with frontal brain lesions: A randomized, controlled double-blind trial
title_sort neurofeedback in patients with frontal brain lesions: a randomized, controlled double-blind trial
topic Human Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521487/
https://www.ncbi.nlm.nih.gov/pubmed/36188178
http://dx.doi.org/10.3389/fnhum.2022.979723
work_keys_str_mv AT annaheimchristine neurofeedbackinpatientswithfrontalbrainlesionsarandomizedcontrolleddoubleblindtrial
AT hugkerstin neurofeedbackinpatientswithfrontalbrainlesionsarandomizedcontrolleddoubleblindtrial
AT stummcaroline neurofeedbackinpatientswithfrontalbrainlesionsarandomizedcontrolleddoubleblindtrial
AT messerlimaya neurofeedbackinpatientswithfrontalbrainlesionsarandomizedcontrolleddoubleblindtrial
AT simonyves neurofeedbackinpatientswithfrontalbrainlesionsarandomizedcontrolleddoubleblindtrial
AT hundgeorgiadismargret neurofeedbackinpatientswithfrontalbrainlesionsarandomizedcontrolleddoubleblindtrial